AH

Ami Hemant Desai

Director Director DIN 07176884
DIN 07176884 First appointment May 2015 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since May 2015
Shareholding value Locked Premium profile

About Ami Hemant Desai

Data last updated:

Ami Hemant Desai has 11 years in corporate governance. Formerly with 1 company, such as Aurochem Pharmaceuticals (India) Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 07176884
Primary Designation Director
First Appointment 05 May 2015
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Additional Director05 May 20151994Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Aurochem Pharmaceuticals (India) Private Limited
Premium access

Shareholding and investment profile for Ami Hemant Desai

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ami Hemant Desai

Ami Hemant Desai has 11 years in corporate governance. Formerly with 1 company, such as Aurochem Pharmaceuticals (India) Private Limited. Engaged in General Business. Contributes to corporate operations.

Ami Hemant Desai is associated with 0 companies as a director.

Ami Hemant Desai has expertise in General Business.

Ami Hemant Desai has 11 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available